Hepatitis C virus: virology and life cycle
Chang Wook Kim, Kyong-Mi Chang
Clin Mol Hepatol. 2013;19(1):17-25. Published online 2013 Mar 25 DOI: https://doi.org/10.3350/cmh.2013.19.1.17
|
Citations to this article as recorded by
Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics
Jie-Li Hu, Ai-Long Huang
Virologica Sinica.2024; 39(1): 9. CrossRef Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn?
Simona Di Martino, Giovanna Li Petri, Maria De Rosa
Journal of Medicinal Chemistry.2024; 67(2): 885. CrossRef EGFR core fucosylation, induced by hepatitis C virus, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defenses
Qiu Pan, Yan Xie, Ying Zhang, Xinqi Guo, Jing Wang, Min Liu, Xiao-Lian Zhang
Nature Communications.2024;[Epub] CrossRef Application of the zebrafish model in human viral research
Jie Liu, Xiaoyi Yuan, Chunxin Fan, Guangyong Ma
Virus Research.2024; 341: 199327. CrossRef Evaluation of interactions between the hepatitis C virus NS3/4A and sulfonamidobenzamide based molecules using molecular docking, molecular dynamics simulations and binding free energy calculations
Jinhong Ren, Tasneem M. Vaid, Hyun Lee, Isabel Ojeda, Michael E. Johnson
Journal of Computer-Aided Molecular Design.2023; 37(1): 53. CrossRef Seroprevalence and Sociodemographic Characteristics for Hepatitis C Infection in North Central Nigeria
Bigwan E.I., Ado S.A., Inabo H.I.
African Journal of Biology and Medical Research.2023; 6(1): 53. CrossRef Potential of CRISPR/Cas system as emerging tools in the detection of viral hepatitis infection
Howra Bahrulolum, Hossein Tarrahimofrad, Fatemeh Nouri Rouzbahani, Saghi Nooraei, Mehdi Mousavi Sameh, Abbas Hajizade, Gholamreza Ahmadian
Virology Journal.2023;[Epub] CrossRef Major genomic mutations driving hepatocellular carcinoma
Ran Chen, Moubin Lin, Daming Gao
Genome Instability & Disease.2023; 4(4): 239. CrossRef Prevalence of Hepatitis C Virus and Its Occult Infection in Hemodialysis Patients
Mohsen Nakhaie, Ehsan Taheri, Javad Charostad, Nasir Arefinia, Davood Kalantar-Neyestanaki, Mohammad Rezaei Zadeh Rukerd, Fatemeh Ahmadpour, Mohamad Hossein Pourebrahimi, Sara Ahmadinejad Farsangi, Sara Shafieipour
Jundishapur Journal of Microbiology.2023;[Epub] CrossRef Efficiency and safety of sofosbuvir in Bangladeshi children with chronic hepatitis C virus infection
Salahuddin Mahmud, Jahida Gulshan, Md. Belayet Hossain, Madhabi Baidya, Rafia Rashid, Farhana Tasneem, Ahmed Rashidul Hasan, Tanzila Farhana, Mohammed Reaz Mobarak, Md. Jahangir Alam, Syed Shafi Ahmed
iLIVER.2023; 2(3): 146. CrossRef Inhibitors Targeting Hepatitis C Virus (HCV) Entry
Paulo Fernando da Silva Santos-Júnior, João Xavier de Araújo-Júnior, Edeildo Ferreira da Silva-Júnior
Mini-Reviews in Medicinal Chemistry.2023; 23(11): 1193. CrossRef Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC
Kholoud Baraka, Rania R. Abozahra, Eman Badr, Sarah M. Abdelhamid
BMC Cancer.2023;[Epub] CrossRef Toll-like receptor 7 and RIG-I-like receptors expression in peripheral blood mononuclear cells of naïve patients with hepatitis C
Atena Gilanipour, Ali Teimoori, Seyed Alimohammad Arabzadeh, Hamid Reza Mollaie, Elham Mousavi
BMC Research Notes.2023;[Epub] CrossRef HCV Genotype Distribution and Clinical Characteristics of HCV Mono-Infected and HCV/HIV Co-Infected Patients in Liangshan Prefecture, Sichuan Province, China
Bianchuan Cao, Mei Liu, Tao Jiang, Qinghua Yu, Tianru Yuan, Ping Ding, Xian Zhou, Yongmao Huang, Yongsheng Zou, Fuli Huang
Journal of the International Association of Providers of AIDS Care (JIAPAC).2023;[Epub] CrossRef CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections
Ulyana I. Bartosh, Anton S. Dome, Natalya V. Zhukova, Polina E. Karitskaya, Grigory A. Stepanov
International Journal of Molecular Sciences.2023; 25(1): 334. CrossRef Electronic nose versus quadrupole mass spectrometry for identifying viral hepatitis C patients
Ehab I. Mohamed, Sameh M. El‐Ghnam, Amani M. Bayoumi, Samir M. Abdel‐Mageed, Doaa A. Ghareeb, Brian Ross
Journal of Viral Hepatitis.2022; 29(2): 147. CrossRef Preclinical mouse models of hepatocellular carcinoma: An overview and update
Catherine Yujia Gu, Terence Kin Wah Lee
Experimental Cell Research.2022; 412(2): 113042. CrossRef Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication
Yaqi Yu, Zhenzhou Wan, Jian-Hua Wang, Xianguang Yang, Chiyu Zhang
Virulence.2022; 13(1): 323. CrossRef Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey
Davaalkham Dambadarjaa, Yerkyebulan Mukhtar, Enkh-Oyun Tsogzolbaatar, Ser-Od Khuyag, Angarmurun Dayan, Nandin-Erdene Oyunbileg, Oyu-Erdene Shagdarsuren, Gunchmaa Nyam, Yosikazu Nakamura, Masaharu Takahashi, Hiroaki Okamoto
Journal of Preventive Medicine and Public Health.2022; 55(3): 263. CrossRef Triazolopyrimidine Nuclei: Privileged Scaffolds for Developing Antiviral
Agents with a Proper Pharmacokinetic Profile
Tommaso Felicetti, Maria Chiara Pismataro, Violetta Cecchetti, Oriana Tabarrini, Serena Massari
Current Medicinal Chemistry.2022; 29(8): 1379. CrossRef Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review
Andri Frediansyah, Fajar Sofyantoro, Saad Alhumaid, Abbas Al Mutair, Hawra Albayat, Hayyan I. Altaweil, Hani M. Al-Afghani, Abdullah A. AlRamadhan, Mariam R. AlGhazal, Safaa A. Turkistani, Abdulmonem A. Abuzaid, Ali A. Rabaan
Molecules.2022; 27(13): 4305. CrossRef The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs
Jan Korbecki, Iwona Szatkowska, Patrycja Kupnicka, Wojciech Żwierełło, Katarzyna Barczak, Iwona Poziomkowska-Gęsicka, Jerzy Wójcik, Dariusz Chlubek, Irena Baranowska-Bosiacka
International Journal of Molecular Sciences.2022; 23(13): 7151. CrossRef Enveloped Viruses: Pathogenetic Targets for Cyanobacterial Lectins
N. N. BESEDNOVA, B. G. ANDRYUKOV, T. S. ZAPOROZHETS, S. P. ERMAKOVA, T. A. KUZNETSOVA, S. P. KRYZHANOVSKY, M. Y. SHCHELKANOV
Antibiotics and Chemotherapy.2022; 67(5-6): 39. CrossRef Nano-formulation of herbo-mineral alternative medicine from linga chenduram and evaluation of antiviral efficacy
Mysoon M. Al-Ansari, A.J.A. Ranjit Singh, Fatimah S. Al-Khattaf, J.S. Michael
Saudi Journal of Biological Sciences.2021; 28(3): 1596. CrossRef Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2
Munazza Shahid, Syed Shahzad-ul-Hussan
Journal of Structural Biology.2021; 213(1): 107690. CrossRef Biophysical approaches promote understanding of the viral replication cycle
Kyung Suk Lee
Journal of the Korean Physical Society.2021; 78(5): 329. CrossRef Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Ragesh B Thandassery, Emmanouil Giorgakis
World Journal of Gastroenterology.2021; 27(24): 3466. CrossRef Genotyping simplified: rationally designed antisense oligonucleotide-mediated PCR amplification-free colorimetric sensing of viral RNA in HCV genotypes 1 and 3
Almas Shamaila Mohammed, Aniket Balapure, Aleem Ahmed Khan, Mahammad Nanne Khaja, Ramakrishnan Ganesan, Jayati Ray Dutta
The Analyst.2021; 146(15): 4767. CrossRef Naked-eye colorimetric detection of HCV RNA mediated by a 5′ UTR-targeted antisense oligonucleotide and plasmonic gold nanoparticles
Almas Shamaila Mohammed, Aniket Balapure, Mahammad Nanne Khaja, Ramakrishnan Ganesan, Jayati Ray Dutta
The Analyst.2021; 146(5): 1569. CrossRef Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteers
H. A. Elmekawy, F. Belal, A. E. Abdelaziz, K. S. Abdelkawy, A. A. Ali, F. Elbarbry
European Journal of Clinical Pharmacology.2021; 77(9): 1369. CrossRef Cyclophilins and Their Roles in Hepatitis C Virus and Flavivirus Infections: Perspectives for Novel Antiviral Approaches
Carla E. Gallardo-Flores, Che C. Colpitts
Pathogens.2021; 10(7): 902. CrossRef Geographical Distribution and Genetic Diversity of Bank Vole Hepaciviruses in Europe
Julia Schneider, Bernd Hoffmann, Cristina Fevola, Marie Luisa Schmidt, Christian Imholt, Stefan Fischer, Frauke Ecke, Birger Hörnfeldt, Magnus Magnusson, Gert E. Olsson, Annapaola Rizzoli, Valentina Tagliapietra, Mario Chiari, Chantal Reusken, Elena Bužan
Viruses.2021; 13(7): 1258. CrossRef Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, Brazil
Ana Paula de Torres Santos, Vanessa Cristina Martins Silva, Maria Cássia Mendes-Corrêa, Marcilio Figueiredo Lemos, Fernanda de Mello Malta, Rúbia Anita Ferraz Santana, Gregório Tadeu Fernando Dastoli, Vanessa Fusco Duarte de Castro, João Renato Rebello Pi
Infection and Drug Resistance.2021; Volume 14: 723. CrossRef Algal and Cyanobacterial Lectins and Their Antimicrobial Properties
José Abel Fernández Romero, María Gabriela Paglini, Christine Priano, Adolfina Koroch, Yoel Rodríguez, James Sailer, Natalia Teleshova
Marine Drugs.2021; 19(12): 687. CrossRef Autophagy in hepatitis B or C virus infection: An incubator and a potential therapeutic target
Lu Zhang
Life Sciences.2020; 242: 117206. CrossRef Management of the Patient With HIV/Hepatitis C Drug Interactions: A Guide for Nurses and Nurse Practitioners
Laura E. Starbird, Hyejeong Hong, Mark S. Sulkowski, Jason E. Farley
Journal of the Association of Nurses in AIDS Care.2020; 31(2): 241. CrossRef Phosphorylated Ezrin (Thr567) Regulates Hippo Pathway and Yes-Associated Protein (Yap) in Liver
Yuhua Xue, Bharat Bhushan, Wendy M. Mars, William Bowen, Junyan Tao, Anne Orr, John Stoops, Yanping Yu, Jianhua Luo, Andrew W. Duncan, George K. Michalopoulos
The American Journal of Pathology.2020; 190(7): 1427. CrossRef Pediatric Hepatitis C
Sara Kathryn Smith
Advances in Pediatrics.2020; 67: 47. CrossRef Role of the Guanine Nucleotide Exchange Factor GBF1 in the Replication of RNA Viruses
José L. Martínez, Carlos F. Arias
Viruses.2020; 12(6): 682. CrossRef The bZIP Proteins of Oncogenic Viruses
Madeleine L. Stolz, Craig McCormick
Viruses.2020; 12(7): 757. CrossRef Effect of P‐body component Mov10 on HCV virus production and infectivity
Dandan Liu, Tanyaradzwa P. Ndongwe, Maritza Puray‐Chavez, Mary C. Casey, Taisuke Izumi, Vinay K. Pathak, Philip R. Tedbury, Stefan G. Sarafianos
The FASEB Journal.2020; 34(7): 9433. CrossRef Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel
World Journal of Gastroenterology.2020; 26(38): 5759. CrossRef Screening and identification of bioactive compounds from citrus against non-structural protein 3 protease of hepatitis C virus genotype 3a by fluorescence resonance energy transfer assay and mass spectrometry
Mahim Khan, Waqar Rauf, Fazal-e- Habib, Moazur Rahman, Mazhar Iqbal
World Journal of Hepatology.2020; 12(11): 976. CrossRef Quantitative detection of hepatitis C virus RNA in urine of patients with chronic hepatitis C using a novel real‐time PCR assay
Tian Lu, Yanxi Han, Rui Zhang, Kuo Zhang, Guigao Lin, Jinming Li
Journal of Medical Virology.2019; 91(1): 115. CrossRef A review on HCV inhibitors: Significance of non-structural polyproteins
Narayana Murthy Ganta, Gangaraju Gedda, Bethi Rathnakar, Mavurapu Satyanarayana, Bhaskar Yamajala, Mohamed Jawed Ahsan, Surender Singh Jadav, Tuniki Balaraju
European Journal of Medicinal Chemistry.2019; 164: 576. CrossRef Effect of sofosbuvir and daclatasvir on lipid profile, glycemic control and quality of life index in chronic hepatitis C, genotype 3 patients
Ayush Jain, Bhupinder Singh Kalra, Siddharth Srivastava, Shalini Chawla
Indian Journal of Gastroenterology.2019; 38(1): 39. CrossRef Seroprevalence and geographical distribution of hepatitis C virus in Iranian patients with thalassemia: a systematic review and meta-analysis
Amir Shamshirian, Reza Alizadeh-Navaei, Ali Akbar Pourfathollah, Reza Alipoor, Ali Reza Mohseni
Journal of Laboratory Medicine.2019; 43(2): 45. CrossRef Discovery, Optimization, and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors
Yiqing Yang, Lin Cao, Hongying Gao, Yue Wu, Yaxin Wang, Fang Fang, Tianlong Lan, Zhiyong Lou, Yu Rao
Journal of Medicinal Chemistry.2019; 62(8): 4056. CrossRef Humanized Mouse Models for the Study of Hepatitis C and Host Interactions
Kylie Su Mei Yong, Zhisheng Her, Qingfeng Chen
Cells.2019; 8(6): 604. CrossRef Effects of free patchy ends in ssDNA and dsDNA on gold nanoparticles in a colorimetric gene sensor for Hepatitis C virus RNA
Almas Shamaila Mohammed, Ravikiran Nagarjuna, Mahammad Nanne Khaja, Ramakrishnan Ganesan, Jayati Ray Dutta
Microchimica Acta.2019;[Epub] CrossRef Geospatial epidemiology of hepatitis C infection in Egypt 2017 by governorate
Engy Mohamed El-Ghitany, Azza Galal Farghaly
Heliyon.2019; 5(8): e02249. CrossRef New Antiviral Agents for Treatment of Hepatitis C
ROBERT S. EGERMAN
Clinical Obstetrics & Gynecology.2019; 62(4): 823. CrossRef CLINICAL MORPHOLOGY OF THE LIVER: HEPATOCYTES, ENDOMEMBRANE SYSTEM
V. M. Tsyrkunov, V. P. Andreev, R. I. Kravchuk
Hepatology and Gastroenterology.2019; 3(1): 28. CrossRef Ghrelin gene polymorphism as a genetic biomarker for prediction of therapy induced clearance in Egyptian chronic HCV patients
Marwa Hamdy, Samar Kamal Kassim, Eman Khairy, Mohsen Maher, Khaled Amr Mansour, Ashraf M Albreedy
Gene.2018; 649: 74. CrossRef Hepatitis C Virus Infection and Vaccine Development
Xuan Guo, Jin-Yi Zhong, Jun-Wen Li
Journal of Clinical and Experimental Hepatology.2018; 8(2): 195. CrossRef A review on current status of antiviral siRNA
Abid Qureshi, Vaqar Gani Tantray, Altaf Rehman Kirmani, Abdul Ghani Ahangar
Reviews in Medical Virology.2018;[Epub] CrossRef Tick-Borne Flaviviruses and the Type I Interferon Response
Richard Lindqvist, Arunkumar Upadhyay, Anna K. Överby
Viruses.2018; 10(7): 340. CrossRef Global epidemiology of viral hepatitis and national needs for complete control
Simone Lanini, Raffaella Pisapia, Maria Rosaria Capobianchi, Giuseppe Ippolito
Expert Review of Anti-infective Therapy.2018; 16(8): 625. CrossRef Assessment of serum level of MiRNAs before and after treatment with sofosbuvir in Egyptian patients with chronic HCV infection
Khalda S. Amr, Wafaa M. Ezzat, SalwaTawfeek, Hassan Elbatae, ImanBayumi, HananAbdelmawgoud Atia, Eman Reda, EmadAbdelsattar, Yasser Elhosary
Meta Gene.2018; 18: 93. CrossRef Transcriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular Carcinoma
Marwa Zahra, Hassan Azzazy, Ahmed Moustafa
Scientific Reports.2018;[Epub] CrossRef Hepatitis C virus-induced hepatocellular carcinoma: a narrative review
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli
Panminerva Medica.2018;[Epub] CrossRef Common viral infections in kidney transplant recipients
Jakapat Vanichanan, Suwasin Udomkarnjananun, Yingyos Avihingsanon, Kamonwan Jutivorakool
Kidney Research and Clinical Practice.2018; 37(4): 323. CrossRef Severe fever with thrombocytopenia syndrome virus inhibits exogenous Type I IFN signaling pathway through its NSs in vitro
Xu Chen, Haiyan Ye, Shilin Li, Baihai Jiao, Jianqin Wu, Peibin Zeng, Limin Chen, Wenyu Lin
PLOS ONE.2017; 12(2): e0172744. CrossRef Hepatitis C
Erin DuHaime
Physician Assistant Clinics.2017; 2(2): 313. CrossRef The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus Genome
Cristina Romero-López, Alfredo Berzal-Herranz
Frontiers in Microbiology.2017;[Epub] CrossRef Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection
Qi Zhang, Liang Wei, Hongchuan Yang, Wanqi Yang, Qingyu Yang, Zhuofan Zhang, Kailang Wu, Jianguo Wu
Cancer Letters.2016; 371(1): 107. CrossRef Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitors
Marta Camarasa, Raimon Puig de la Bellacasa, Àlex L. González, Raül Ondoño, Roger Estrada, Sandra Franco, Roger Badia, José Esté, Miguel Ángel Martínez, Jordi Teixidó, Bonaventura Clotet, José I. Borrell
European Journal of Medicinal Chemistry.2016; 115: 463. CrossRef In silico study on baicalein and baicalin as inhibitors of dengue virus replication
Pouya Hassandarvish, Hussin A. Rothan, Sahar Rezaei, Rohana Yusof, Sazaly Abubakar, Keivan Zandi
RSC Advances.2016; 6(37): 31235. CrossRef Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature
S. K. Basnayake, P. J. Easterbrook
Journal of Viral Hepatitis.2016; 23(7): 545. CrossRef Review article: treatment as prevention – targeting people who inject drugs as a pathway towards hepatitis C eradication
J. D. Leask, J. F. Dillon
Alimentary Pharmacology & Therapeutics.2016; 44(2): 145. CrossRef Hepatitis C Viral Infection in Children: Updated Review
Mohamed A. El-Guindi
Pediatric Gastroenterology, Hepatology & Nutrition.2016; 19(2): 83. CrossRef Demographics of Hepatitis C in Southwest Ohio (2010 to 2015)
Jon Woltmann, Patrick Burke, Rebecca Brady, Jason T Blackard
Hepatitis Monthly.2016;[Epub] CrossRef Prospects for the design of new therapeutically significant protease inhibitors based on knottins and sunflower seed trypsin inhibitor (SFTI 1)
S.S. Kuznetsova, E.F. Kolesanova, A.V. Talanova, A.V. Veselovsky
Biomeditsinskaya Khimiya.2016; 62(4): 353. CrossRef Development of a rapid phenotypic test for HCV protease inhibitors with potential use in clinical decisions
Luciana Santos Pessoa, Luãnna Liebscher Vidal, Emmerson C.B. da Costa, Celina Monteiro Abreu, Rodrigo Delvecchio da Cunha, Ana Luiza Chaves Valadão, André Felipe dos Santos, Amilcar Tanuri
Genetics and Molecular Biology.2016; 39(3): 358. CrossRef Development of Rous sarcoma Virus-like Particles Displaying hCC49 scFv for Specific Targeted Drug Delivery to Human Colon Carcinoma Cells
Tatsuya Kato, Megumi Yui, Vipin Kumar Deo, Enoch Y. Park
Pharmaceutical Research.2015; 32(11): 3699. CrossRef The STAT3-regulated long non-coding RNA Lethe promote the HCV replication
Yulin Xiong, Jing Yuan, Changjiang Zhang, Yan Zhu, Xuemei Kuang, Lin Lan, Xiaohong Wang
Biomedicine & Pharmacotherapy.2015; 72: 165. CrossRef The 3D-QSAR and pharmacophore studies of pyrimidine derivatives as HCV replication (replicase) inhibitor
Yan Li, Dechao Wang, Yinfeng Yang, Jingxiao Zhang, Chunxiao Han, Jinghui Wang, Weimin Gao, Guomei Zhang, Xiaoqian Sun, Bingchen Wang, Shuwei Zhang, Ling Yang
Medicinal Chemistry Research.2015; 24(5): 2033. CrossRef Aptamer-conjugated magnetic nanoparticles for the efficient removal of HCV particles from human plasma samples
Najmeh Delaviz, Pooria Gill, Abolghasem Ajami, Mohsen Aarabi
RSC Advances.2015; 5(97): 79433. CrossRef STAT3-regulated long non-coding RNAs lnc-7SK and lnc-IGF2-AS promote hepatitis C virus replication
YULIN XIONG, MING JIA, JING YUAN, CHANGJIANG ZHANG, YAN ZHU, XUEMEI KUANG, LIN LAN, XIAOHONG WANG
Molecular Medicine Reports.2015; 12(5): 6738. CrossRef Hepatitis C Virus–Associated Cancer
Ming V. Lin, Lindsay Y. King, Raymond T. Chung
Annual Review of Pathology: Mechanisms of Disease.2015; 10(1): 345. CrossRef Disability adjusted life year (DALY): A useful tool for quantitative assessment of environmental pollution
Tingting Gao, Xiaochang C. Wang, Rong Chen, Huu Hao Ngo, Wenshan Guo
Science of The Total Environment.2015; 511: 268. CrossRef A Combined Proteomics/Genomics Approach Links Hepatitis C Virus Infection with Nonsense-Mediated mRNA Decay
Holly R. Ramage, G. Renuka Kumar, Erik Verschueren, Jeffrey R. Johnson, John Von Dollen, Tasha Johnson, Billy Newton, Priya Shah, Julie Horner, Nevan J. Krogan, Melanie Ott
Molecular Cell.2015; 57(2): 329. CrossRef Viral Load Analysis of Hepatitis C Virus in Huh7.5 Cell Culture System
Roghayeh Teimourpour, Zahra Meshkat, Aida Gholoubi, Hosein Nomani, Sina Rostami
Jundishapur Journal of Microbiology.2015;[Epub] CrossRef Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C
Alena M. Pfeil, Oliver Reich, Ines M. Guerra, Sandrine Cure, Francesco Negro, Beat Müllhaupt, Daniel Lavanchy, Matthias Schwenkglenks, Chen-Hua Liu
PLOS ONE.2015; 10(5): e0126984. CrossRef Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees
Babs E Verstrepen
World Journal of Hepatology.2015; 7(1): 53. CrossRef Genetic heterogeneity of hepatitis C virus cell entry receptors seems to have no influence on selection of virus variants
Maren Lipskoch, Manfred Wiese, Joerg Timm, Michael Roggendorf, Sergei Viazov
Virology Journal.2014;[Epub] CrossRef Antiviral therapy for chronic hepatitis C in 2014
Manogna Nookathota, Sandeep Mukherjee
Expert Review of Clinical Pharmacology.2014; 7(4): 499. CrossRef Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations
Clara T. M. M. de Kanter, Joost P. H. Drenth, Joop E. Arends, Henk W. Reesink, Marc van der Valk, Robert J. de Knegt, David M. Burger
Clinical Pharmacokinetics.2014; 53(5): 409. CrossRef Rapid and sensitive approach to simultaneous detection of genomes of hepatitis A, B, C, D and E viruses
Maja Kodani, Tonya Mixson-Hayden, Jan Drobeniuc, Saleem Kamili
Journal of Clinical Virology.2014; 61(2): 260. CrossRef The role of microRNAs in Hepatitis C Virus replication and related liver diseases
Chang Ho Lee, Ji Hyun Kim, Seong-Wook Lee
Journal of Microbiology.2014; 52(6): 445. CrossRef Actualización en el tratamiento de la hepatitis C
E. Rodríguez de Santiago, J. Martínez González, F. Gea Rodríguez, A. Albillos Martínez
Medicine - Programa de Formación Médica Continuada Acreditado.2014; 11(69): 4103. CrossRef Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant
Christine Hartoonian, Zargham Sepehrizadeh, Mehdi Mahdavi, Arash Arashkia, Yon Suk Jang, Maasoumeh Ebtekar, Mojtaba Tabatabai Yazdi, Babak Negahdari, Azita Nikoo, Kayhan Azadmanesh
Molecular Biology Reports.2014; 41(9): 5943. CrossRef Enhancement of Immune Responses by Co-delivery of CCL19/MIP-3beta Chemokine Plasmid With HCV Core DNA/Protein Immunization
Christine Hartoonian, Zargham Sepehrizadeh, Mojtaba Tabatabai Yazdi, Yong Suk Jang, Lida Langroudi, Parisa Amir Kalvanagh, Babak Negahdari, Ali Karami, Massoumeh Ebtekar, Kayhan Azadmanesh
Hepatitis Monthly.2014;[Epub] CrossRef Accounting for Target Flexibility and Water Molecules by Docking to Ensembles of Target Structures: The HCV NS5B Palm Site I Inhibitors Case Study
Maria Letizia Barreca, Nunzio Iraci, Giuseppe Manfroni, Rosy Gaetani, Chiara Guercini, Stefano Sabatini, Oriana Tabarrini, Violetta Cecchetti
Journal of Chemical Information and Modeling.2014; 54(2): 481. CrossRef Global fold and backbone dynamics of the hepatitis C virus E2 glycoprotein transmembrane domain determined by NMR
Hila Shalom-Elazari, Hadas Zazrin-Greenspon, Hadassa Shaked, Jordan H. Chill
Biochimica et Biophysica Acta (BBA) - Biomembranes.2014; 1838(11): 2919. CrossRef MicroRNA-27a Modulates HCV Infection in Differentiated Hepatocyte-Like Cells from Adipose Tissue-Derived Mesenchymal Stem Cells
Jung Eun Choi, Wonhee Hur, Jung-Hee Kim, Tian Zhu Li, Eun Byul Lee, Sung Won Lee, Wonseok Kang, Eui-Cheol Shin, Takaji Wakita, Seung Kew Yoon, Sean Bong Lee
PLoS ONE.2014; 9(5): e91958. CrossRef
|